Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 2
2003 2
2004 1
2005 2
2006 2
2007 2
2008 1
2010 1
2012 3
2013 1
2014 2
2015 1
2016 1
2017 6
2018 6
2019 3
2020 3
2021 5
2022 1
2023 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

45 results

Results by year

Filters applied: . Clear all
Page 1
2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism.
Konstantinides SV, Torbicki A, Agnelli G, Danchin N, Fitzmaurice D, Galiè N, Gibbs JS, Huisman MV, Humbert M, Kucher N, Lang I, Lankeit M, Lekakis J, Maack C, Mayer E, Meneveau N, Perrier A, Pruszczyk P, Rasmussen LH, Schindler TH, Svitil P, Vonk Noordegraaf A, Zamorano JL, Zompatori M; Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC). Konstantinides SV, et al. Eur Heart J. 2014 Nov 14;35(43):3033-69, 3069a-3069k. doi: 10.1093/eurheartj/ehu283. Epub 2014 Aug 29. Eur Heart J. 2014. PMID: 25173341 Free article. No abstract available.
Impact of Thrombolytic Therapy on the Long-Term Outcome of Intermediate-Risk Pulmonary Embolism.
Konstantinides SV, Vicaut E, Danays T, Becattini C, Bertoletti L, Beyer-Westendorf J, Bouvaist H, Couturaud F, Dellas C, Duerschmied D, Empen K, Ferrari E, Galiè N, Jiménez D, Kostrubiec M, Kozak M, Kupatt C, Lang IM, Lankeit M, Meneveau N, Palazzini M, Pruszczyk P, Rugolotto M, Salvi A, Sanchez O, Schellong S, Sobkowicz B, Meyer G. Konstantinides SV, et al. Among authors: becattini c. J Am Coll Cardiol. 2017 Mar 28;69(12):1536-1544. doi: 10.1016/j.jacc.2016.12.039. J Am Coll Cardiol. 2017. PMID: 28335835 Free article. Clinical Trial.
BACKGROUND: The long-term effect of thrombolytic treatment of pulmonary embolism (PE) is unknown. ...RESULTS: Long-term (median 37.8 months) survival was assessed in 353 of 359 (98.3%) patients in the thrombolysis arm and in 343 of 350 (98.0%) in the placebo arm. .. …
BACKGROUND: The long-term effect of thrombolytic treatment of pulmonary embolism (PE) is unknown. ...RESULTS: Long-term (media …
Long-term treatment of venous thromboembolism.
Becattini C, Manina G. Becattini C, et al. Curr Vasc Pharmacol. 2014 May;12(3):384-92. doi: 10.2174/157016111203140518154040. Curr Vasc Pharmacol. 2014. PMID: 24846227 Review.
Long term treatment of venous thromboembolism is essential to complete therapy of the index episode and to reduce recurrences. ...Low-molecular weight heparins are recommended for the long term treatment of cancer patients. The duration of long term anticoagu …
Long term treatment of venous thromboembolism is essential to complete therapy of the index episode and to reduce recurrences. ...Low …
Acute treatment of venous thromboembolism.
Becattini C, Agnelli G. Becattini C, et al. Blood. 2020 Jan 30;135(5):305-316. doi: 10.1182/blood.2019001881. Blood. 2020. PMID: 31917399 Free article. Review.
Initial anticoagulant treatment is crucial for reducing mortality, preventing early recurrences, and improving long-term outcome. Treatment and patient disposition should be tailored to the severity of clinical presentation, to comorbidities, and to the potential to receiv …
Initial anticoagulant treatment is crucial for reducing mortality, preventing early recurrences, and improving long-term outcome. Tre …
Contemporary Management and Clinical Course of Acute Pulmonary Embolism: The COPE Study.
Becattini C, Agnelli G, Maggioni AP, Dentali F, Fabbri A, Enea I, Pomero F, Ruggieri MP, di Lenarda A, Cimini LA, Pepe G, Cozzio S, Lucci D, Gulizia MM; COPE Investigators. Becattini C, et al. Thromb Haemost. 2023 Jun;123(6):613-626. doi: 10.1055/a-2031-3859. Epub 2023 Feb 9. Thromb Haemost. 2023. PMID: 36758612 Free PMC article.
BACKGROUND: New diagnosis, risk stratification, and treatment strategies became recently available for patients with acute pulmonary embolism (PE) leading to changes in clinical practice and potentially influencing short-term patients' outcomes. RESEARCH QUESTION: The COnt …
BACKGROUND: New diagnosis, risk stratification, and treatment strategies became recently available for patients with acute pulmonary embolis …
New oral anticoagulants for the treatment of venous thromboembolism.
Agnelli G, Becattini C, Franco L. Agnelli G, et al. Among authors: becattini c. Best Pract Res Clin Haematol. 2013 Jun;26(2):151-61. doi: 10.1016/j.beha.2013.07.005. Epub 2013 Jul 22. Best Pract Res Clin Haematol. 2013. PMID: 23953903 Review.
New oral anticoagulants, acting either as direct factor-Xa or thrombin inhibitors, have been evaluated for the acute and long-term treatment of venous thromboembolism (VTE). Dabigatran and rivaroxaban are as effective as conventional therapy (heparin/vitamin K antagonists) …
New oral anticoagulants, acting either as direct factor-Xa or thrombin inhibitors, have been evaluated for the acute and long-term tr …
Definition of major bleeding: Prognostic classification.
Franco L, Becattini C, Beyer-Westendorf J, Vanni S, Nitti C, Re R, Manina G, Pomero F, Cappelli R, Conti A, Agnelli G. Franco L, et al. Among authors: becattini c. J Thromb Haemost. 2020 Nov;18(11):2852-2860. doi: 10.1111/jth.15048. Epub 2020 Sep 11. J Thromb Haemost. 2020. PMID: 32767653 Free article.
However, this definition identifies MBs with highly variable short-term risk of death. OBJECTIVES: The study aims were to derive and validate a classification of ISTH-defined MBs for the risk of short-term death. ...A prognostic classification of ISTH-defined MBs fo …
However, this definition identifies MBs with highly variable short-term risk of death. OBJECTIVES: The study aims were to derive and …
The risk of stroke recurrence in patients with atrial fibrillation and reduced ejection fraction.
RAF and RENO-EXTEND Investigators. RAF and RENO-EXTEND Investigators. Eur Stroke J. 2023 Sep;8(3):731-737. doi: 10.1177/23969873231177625. Epub 2023 May 30. Eur Stroke J. 2023. PMID: 37249094 Free PMC article.
CONCLUSIONS: In patients with ischemic stroke and AF, the presence of rEF was not associated with the composite outcome of ischemic or hemorrhagic events over short-term follow-up but was associated with increased mortality or disability....
CONCLUSIONS: In patients with ischemic stroke and AF, the presence of rEF was not associated with the composite outcome of ischemic or hemor …
Acute Pulmonary Embolism after Discharge: Duration of Therapy and Follow-up Testing.
Becattini C, Franco L, Agnelli G. Becattini C, et al. Semin Respir Crit Care Med. 2017 Feb;38(1):94-106. doi: 10.1055/s-0036-1597557. Epub 2017 Feb 16. Semin Respir Crit Care Med. 2017. PMID: 28208203 Review.
Current recommendations on duration of anticoagulation are based on a 3% per year risk of major bleeding expected during long-term warfarin treatment. Anticoagulant therapy should be discontinued after the initial 3 to 6 months in those patients who had the first episode i …
Current recommendations on duration of anticoagulation are based on a 3% per year risk of major bleeding expected during long-term wa …
45 results